Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1428 | AZD5363 | 0.003162278 | 2.3054 | -0.00220 |
| HCC1428 | RO-3306 | 0.031622777 | 2.2950 | -0.02655 |
| HCC1428 | THZ531 | 0.01 | 2.2847 | -0.01119 |
| HCC1428 | AZD5363 | 0.1 | 2.2744 | 0.00046 |
| HCC1500 | AZD5363 | 0.316227766017 | 2.2506 | -0.20299 |
| HCC1500 | AZD5363 | 0.316227766017 | 2.2206 | -0.22546 |
| HCC1500 | AZD6738 | 0.00316227766017 | 2.1613 | -0.20617 |
| HCC1500 | GSK2334470 | 0.001 | 2.1613 | -0.13323 |
| HCC1428 | Alvocidib | 0.0001 | 2.1522 | -0.02854 |
| HCC1428 | AZD6738 | 0.003162278 | 2.1422 | -0.01891 |
| HCC1500 | AZD6738 | 3.16227766017 | 2.1320 | -0.19140 |
| HCC1500 | SHP099 | 1.0 | 2.0455 | -0.19085 |
| HCC1500 | AZD6738 | 0.316227766017 | 1.9890 | -0.16855 |
| HCC1500 | AZD6738 | 0.001 | 1.9890 | -0.21843 |
| HCC1500 | Rucaparib | 1.0 | 1.9611 | -0.19121 |
| HCC1500 | AZD6738 | 0.01 | 1.9060 | -0.22086 |
| HCC1428 | AZD5363 | 10.0 | 1.8891 | -0.02104 |
| HCC1428 | AZD5363 | 10.0 | 1.8797 | -0.00266 |
| HCC1500 | AZD5363 | 1.0 | 1.8788 | -0.18704 |
| HCC1500 | THZ531 | 0.0001 | 1.8788 | -0.22658 |
| HCC1500 | Ribociclib | 0.0316227766017 | 1.8517 | -0.16158 |
| HCC1428 | AZD6738 | 1.0 | 1.8421 | -0.01018 |
| HCC1428 | AZD6738 | 3.16227766 | 1.8421 | -0.02980 |
| HCC1500 | Ribociclib | 10.0 | 1.8249 | -0.12891 |
| MDA-MB-157 | AZD6738 | 0.01 | 1.7949 | -0.02451 |